Thalidomide: An Overview and the Species-Specific Teratogenicity

Conclusion: Outside clinical trials, vtD remains a superior induction regimen compared with TD in transplant-eligible, newly diagnosed patients ...







16-Thalidomide and dexamethasone oral SUPERSEDED | eviQ
They showed that single-agent thalidomide can induce a partial response in approximately 30% of patients with refractory myeloma. The combination of thalido-.
Thalidomide for Treating Metastatic Hepatocellular Carcinoma
Furthermore, the TD regimen was administered to eight patients with primary refractory myeloma who were eligible for high-dose therapy with autologous stem cell.
The Thalidomide Story
Thalidomide (TD) was first developed as a safe sedative hypnotic in 1958 and was prescribed for pregnant women to prevent morning sickness.



Autres Cours:

Site Plan Review Regulations - As Amended December 1, 2015